Dilaforette has received SEK2.85m ($425m) to develop sevuparin, a new treatment for severe malaria from Vinnova, a Swedish Governmental Agency. Sevuparin is an adjunctive therapy to anti-parasite medicines to prevent the infected red ...
Tags: Dilaforette, sevuparin, severe malaria
Hospira has announced a nationwide voluntary recall of one lot of Hydromorphone Injection, USP, 2mg/mL (C-II), 1mL fill in 2.5mL Carpuject, NDC 0409-1312-30 , due to a reported complaint of a single Carpuject containing more than the 1mL ...
Mylan Pharmaceuticals has received final FDA approval for its abbreviated new drug application (ANDA) for Lithium Carbonate Extended-release tablets USP, 300mg. Mylan has announced immediate shipment of the generic version of Noven ...
Tags: new drug, Lithium Carbonate Extended-release tablets USP, manic episodes
The package, which will launch at more than 3,600 Walmart pharmacies this summer, features a tear-resistant, recyclable outer carton, an easy-slide blister and an integrated calendar for patients to easily track their medications. ...
Janssen Pharmaceuticals has signed a licensing deal with Depomed for its Acuform gastric retentive drug delivery technology. As per the agreement, Janssen gained non-exclusive license and other rights to certain Acuform patents and in ...
Tags: Janssen Pharmaceuticals, Acuform Patents, drug delivery technology
Antares Pharma and Watson Pharmaceuticals have introduced Gelnique 3% (oxybutynin) gel 3%, for the treatment of overactive bladder (OAB). The product is available in a metered pump dispenser and is delivered transdermally, resulting in a ...
The US Food and Drug Administration (FDA) has granted 510(k) approval to Teleflex Incorporated's ArrowADVANTAGE5 non-coated pressure-injectable peripherally inserted central catheter (PICC) for central venous pressure (CVP) monitoring ...
Tags: pressure-injectable, central venous pressure, CVP, central catheter
Validus Pharmaceuticals and Wood Creek Capital Management have acquired the US rights to six product lines from Novartis Pharmaceuticals Corporation (NPC). The acquired six product lines include Lopressor (metoprolol tartrate USP) ...
The rlc packaging has completed the expansion of its PHARMACENTER in Rüdersdorf, Germany. The new production facility with doubled machine capacity is designed to meet the growing demand for pharmaceutical packaging, according to the ...
Tags: production facility, pharmaceutical packaging, new production line
Ten biopharmaceutical companies, Abbott, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Johnson & Johnson, Pfizer, Genentech and Sanofi have established a non-profit organization ...
Tags: biopharmaceutical companies, non-profit organization, new medicines
ViSc, a subsidiary of BioLight Life Science Investments, has entered into an option agreement to license Aerie Pharmaceuticals' controlled-release Eye-D drug delivery technology. Under the license agreement, the technology, which will be ...
The US Food and Drug Administration (FDA) has approved Eisai's non-competitive AMPA glutamate receptor antagonist for patients who continue to have seizures despite being on other prescription medications for epilepsy. The drug, ...
There are so many reasons why you would need or just want a house generator. Besides house generators being convenient, a house generator can keep you, your family and your neighbors safe from many potential problems. In this section of ...
Tags: Learning Center, Generator
The night watchman and the IT security guy rarely work together even though their jobs,at the core,are similar:to protect the company.At many organizations,physical and information security remain separate entities by happenstance and by ...
The US Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) of Boehringer Ingelheim Pharmaceuticals and Eli Lilly and Company for Tradjenta (linagliptin) tablets for use as add-on therapy to insulin. ...
Tags: FDA, sNDA, pharmaceutical product, clinical development